MONICA BRIONES: Open Payments
NPI 1265449094 · EDGEWOOD, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 33 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $242 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Lilly USA, LLC | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| Novo Nordisk Inc | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Viatris Specialty LLC | 1 | $22 |
Products named: REXULTI, Kerendia, EVENITY, Veozah, Wegovy, MOUNJARO, XIFAXAN, JARDIANCE.
Industry payments across NM — which companies pay providers there.
